C
Shockwave Medical, Inc. SWAV
$328.99 $0.120.04%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)
C
Hold 2/27/2024Downgrade
Shockwave Medical, Inc. (SWAV) was downgraded to C from C+ on 2/27/2024 due to a substantial decline in the valuation index and growth index.
C
Hold 2/22/2024Upgraded
Shockwave Medical, Inc. (SWAV) was upgraded to C+ from C on 2/22/2024 due to an increase in the total return index.
C
Hold 11/24/2023Downgrade
Shockwave Medical, Inc. (SWAV) was downgraded to C from C+ on 11/24/2023 due to a decline in the total return index.
C
Hold 11/9/2023Upgraded
Shockwave Medical, Inc. (SWAV) was upgraded to C+ from C on 11/9/2023 due to a large increase in the growth index, valuation index and efficiency index. Total capital increased 102.1% from $675.97M to $1.37B, EBIT increased 36.91% from $32.37M to $44.32M, and operating cash flow increased 27.47% from $39.74M to $50.65M.
C
Hold 9/12/2023Downgrade
Shockwave Medical, Inc. (SWAV) was downgraded to C from C+ on 9/12/2023 due to a decline in the total return index and valuation index.
C
Hold 8/28/2023Upgraded
Shockwave Medical, Inc. (SWAV) was upgraded to C+ from C on 8/28/2023 due to an increase in the total return index and valuation index.
C
Hold 8/10/2023Downgrade
Shockwave Medical, Inc. (SWAV) was downgraded to C from C+ on 8/10/2023 due to a noticeable decline in the total return index and growth index. Earnings per share declined from $1.03 to $0.76, and EBIT declined 18.69% from $39.81M to $32.37M.
C
Hold 5/10/2023Upgraded
ShockWave Medical, Inc. (SWAV) was upgraded to C+ from C on 5/10/2023 due to a large increase in the total return index.
C
Hold 3/1/2023Upgraded
ShockWave Medical, Inc. (SWAV) was upgraded to C from C- on 3/1/2023 due to a major increase in the valuation index, growth index and efficiency index. Net income increased 302.57% from $35M to $140.91M, earnings per share increased from $0.92 to $3.7025, and operating cash flow increased 52.04% from $34.49M to $52.44M.
C
Hold 2/8/2023Downgrade
ShockWave Medical, Inc. (SWAV) was downgraded to C- from C on 2/8/2023 due to a decline in the volatility index.
C
Hold 1/24/2023Upgraded
ShockWave Medical, Inc. (SWAV) was upgraded to C from C- on 1/24/2023 due to an increase in the valuation index.
C
Hold 1/5/2023Downgrade
ShockWave Medical, Inc. (SWAV) was downgraded to C- from C on 1/5/2023 due to a major decline in the total return index.
C
Hold 5/23/2022Upgraded
ShockWave Medical, Inc. (SWAV) was upgraded to C from C- on 5/23/2022 due to a large increase in the total return index and volatility index.
C
Hold 5/10/2022Upgraded
ShockWave Medical, Inc. (SWAV) was upgraded to C- from D on 5/10/2022 due to a significant increase in the efficiency index and valuation index. Net income increased 12.2% from $12.94M to $14.52M, and total capital increased 10.29% from $289.02M to $318.76M.
D
Sell 5/5/2022Upgraded
ShockWave Medical, Inc. (SWAV) was upgraded to D from D- on 5/5/2022 due to an increase in the total return index and valuation index.
D
Sell 4/20/2022Downgrade
ShockWave Medical, Inc. (SWAV) was downgraded to D- from D on 4/20/2022 due to a significant decline in the total return index and volatility index.
D
Sell 11/9/2021Upgraded
ShockWave Medical, Inc. (SWAV) was upgraded to D from D- on 11/9/2021 due to an increase in the solvency index and valuation index. Debt to equity declined from 0.09 to 0.08.
D
Sell 11/8/2021Downgrade
ShockWave Medical, Inc. (SWAV) was downgraded to D- from D on 11/8/2021 due to a large decline in the efficiency index, valuation index and solvency index. The quick ratio declined from 5.88 to 5.55.
D
Sell 10/1/2019Downgrade
ShockWave Medical, Inc. (SWAV) was downgraded to D from D+ on 10/1/2019 due to a large decline in the volatility index and total return index.
D
Sell 8/8/2019None
Shockwave Medical, Inc. (SWAV) was downgraded to D+ from U on 08/08/2019.
Weiss Ratings